Recro Pharma, Inc.

Hello, thank you for standing by and welcome to the RECRO second quarter 2021 conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Stephanie Diaz, Investor Relations, Please go ahead.

Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO, and Ryan Lake, Chief Financial Officer. Today, we will be providing an overview of reclosed contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended June 30th, 2021. After our prepared remarks, we will welcome your questions. Before we begin, I'd like to caution that comments made during this conference call today, August 9th, 2021, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the current beliefs of the company, which include a number of assumptions, risks, and uncertainties. Actual results could differ from these statements, and the company undertakes no obligation to revise or update any statement made today. I encourage you to review all of the company's filings with the Securities and Exchange Commission concerning these and other matters. Our earnings press release and this call will include discussion of certain non-GAAP information. You can find our earnings press release, including relevant non-GAAP reconciliations, on our corporate website at RecroCDMO.com. With that, I will turn the call over to David Enloe, Recro's President and CEO.

Thank you, Stephanie, and thank you to everyone who has dialed in and to those who are participating today via webcast. This is a very exciting time at RECRO. Today, the company is pleased to report strong second quarter earnings as well as the addition of multiple new customers and projects to our pipeline. During the quarter, the company also significantly strengthened its financial position with the closing of an oversubscribed underwritten public offering in May that raised net proceeds of $32.1 million. These funds, combined with strategic paydowns of the company's outstanding credit facility during 2021, have substantially increased our cash balance and reduced our debt. And finally, the company continued to strengthen the business through leadership and talent with two key appointments and achieved milestones that enhance our operational capabilities and competencies. I will provide additional details on all of those achievements following an overview of our Q2 and six-month financial results. For that, I'll turn the call over to Ryan.